跳至主要内容
临床试验/PACTR202203682996126
PACTR202203682996126招募中4 期

The role of Intrathecal Neostigmine as an Adjuvant to Bupivacaine in Ameliorating Post-Dural Puncture Headache for Elective Caesarian Section: A Prospective Randomized Controlled Clinical Trial

Alexandria University Hospital0 个研究点目标入组 722 人开始时间: 2022年3月15日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
722

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • American society association (ASA) physical status class II parturients with a single fetus who will be scheduled for an elective caesarian section by Intrathecal block.

排除标准

  • Body mass index more than or equal to 35 kg/m2.
  • Any contraindication to Intrathecal blocks such as local infection, bleeding disorders, or parturient refusal.
  • Allergy to neostigmine or other drugs will be used in the study.
  • Long-term opioid use.
  • A history of chronic pain, migraine, cluster headache.
  • Digestive problems with nausea and vomiting; cognitive dysfunction or memory disorders.
  • Significant renal, hepatic, and cardiovascular diseases.
  • History of urinary retention or bronchial asthma.
  • Inadequate or failed Intrathecal block.
  • Complicated pregnancy such as hypertensive disorders of the pregnancy, abnormal placenta, or uterine atony.

研究者

发起方
Alexandria University Hospital

相似试验